Status: Recruiting
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
The main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.
Participants needed: 20
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Johns Hopkins UniversityUpdated: Feb 13, 2026Locations: 1
Eligibility criteria
Over age 18 years, inclusive. [+12]
selective serotonin reuptake inhibitor (SSRI) [+35]